Men's Health · HPG-axis neuropeptide · Compounded 503A
Kisspeptin-10: the upstream switch of the HPG axis.
Kisspeptin is the upstream signal that initiates puberty and sustains the hypothalamic-pituitary-gonadal (HPG) axis in adulthood. Kisspeptin-10 — the active C-terminal fragment — has been studied for restoring endogenous testosterone production, supporting fertility, and as a non-suppressive alternative to exogenous testosterone in select patients.
Free shipping over $150 · Pay with card or crypto
What Kisspeptin-10 is
Kisspeptin is a family of peptides encoded by the KISS1 gene. Kisspeptin-10 is the bioactive C-terminal decapeptide — the shortest fragment that retains full agonist activity at the KISS1R (GPR54) receptor.
The kisspeptin–GPR54 system is the master regulator of reproductive function. Mutations in KISS1R cause hypogonadotropic hypogonadism; activating mutations cause precocious puberty. It sits upstream of GnRH, LH/FSH, and gonadal hormone production.
In clinical research, kisspeptin-10 has been used as a diagnostic and therapeutic tool for hypothalamic amenorrhea, functional hypothalamic disorders, and fertility evaluation — and in men, as a stimulant of endogenous testosterone production.
How it works
Kisspeptin-10 binds KISS1R on GnRH neurons in the hypothalamus, triggering GnRH release. GnRH then drives pituitary LH and FSH secretion, which in turn stimulate gonadal steroidogenesis (testosterone in men, estradiol and progesterone in women) and gametogenesis.
Critically, kisspeptin works upstream — it amplifies the body's own pulsatile reproductive axis rather than replacing or suppressing it. This is the structural contrast with exogenous testosterone, which suppresses LH/FSH and shuts down endogenous production.
Pulsatile, time-limited dosing is the natural physiology — and most clinical protocols mirror that pattern rather than continuous administration.
What patients use it for
Endogenous testosterone support
Stimulates the body's own LH/FSH axis to raise testosterone — without suppressing testicular function the way exogenous TRT does.
Fertility preservation
Because the HPG axis remains active, spermatogenesis and testicular volume are preserved — a key advantage over standard TRT for men who want fertility intact.
HPG axis restart
Used in protocols to restart the natural axis after long-term TRT or post-cycle from anabolic steroid use.
Female reproductive support
In women with functional hypothalamic amenorrhea, kisspeptin restores LH pulsatility and ovarian function in research settings.
Evidence summary
Dhillo WS et al. (Journal of Clinical Endocrinology & Metabolism, 2005) demonstrated that kisspeptin-54 injection robustly raises LH, FSH, and testosterone in healthy men — the foundational human pharmacology paper.
George JT et al. (JCEM, 2011) showed kisspeptin-10 restores LH pulsatility and testosterone in men with hypogonadotropic hypogonadism.
Jayasena CN et al. (JCI, 2014) demonstrated kisspeptin restores reproductive function in women with hypothalamic amenorrhea — extending the use case to women's reproductive medicine.
Clinical use as a TRT alternative or fertility-preserving testosterone strategy exceeds the published RCT base. Honest framing: well-established upstream pharmacology, growing but still early outcome literature.
Dosing and clinical context
General clinical context only. Kindr Health physicians determine the appropriate dose and protocol for each patient based on history and labs. This is not a prescription or dosing recommendation.
Most commonly subcutaneous injection, dosed pulsatile (every 1–2 days or in short cycles) rather than continuously — to mirror native physiology.
Typical research doses range from 50 mcg to several hundred mcg per dose; clinical compounded dosing varies by indication and provider.
Compounded kisspeptin-10 from licensed 503A pharmacies is the typical U.S. dispensing pathway.
Safety and contraindications
Generally well-tolerated in clinical studies. The main consideration is HPG-axis stimulation — patients with hormone-sensitive cancers should not use it.
Contraindications: prostate cancer, breast cancer, pregnancy, uncontrolled cardiovascular disease, polycythemia.
Off-label use under physician supervision through a licensed 503A pharmacy. Not FDA-approved.
Who it's typically considered for
- Men with secondary hypogonadism wanting endogenous testosterone support without TRT suppression
- Men on long-term TRT considering an HPG-axis restart for fertility
- Men with subfertility or low testicular volume seeking alternatives to clomid or hCG
- Patients prioritizing fertility preservation
Frequently asked questions
Is kisspeptin-10 the same as TRT?
No — they're opposite in direction. TRT replaces testosterone from outside and suppresses the natural axis. Kisspeptin stimulates the natural axis to produce more testosterone internally.
Will kisspeptin-10 shrink my testicles like TRT can?
No. Because the LH/FSH signal stays active, testicular volume and spermatogenesis are preserved — the opposite of what happens on standard TRT.
Is kisspeptin-10 FDA-approved?
No. Kisspeptin-10 is investigational; compounded preparations are dispensed by licensed 503A pharmacies under physician prescription for off-label use.
Kisspeptin vs hCG vs clomid?
All three drive endogenous testosterone, but at different points. Clomid blocks estrogen receptor feedback at the hypothalamus. hCG mimics LH at the testes. Kisspeptin acts upstream of all of them, at the hypothalamic GnRH neuron.
Can women use kisspeptin-10?
Yes — research has demonstrated efficacy in women with hypothalamic amenorrhea. Clinical use in women is less common in U.S. compounded practice but has a strong research basis.
How quickly does it work?
Acute LH and testosterone rises are measurable within hours of injection. Sustained clinical effects on energy, libido, and labs typically take 4–8 weeks of consistent dosing.
Is kisspeptin-10 safe long-term?
Long-term safety data is limited. Periodic monitoring of hormone panels and prostate markers is appropriate. Discuss with your physician.
Sources
- Dhillo WS et al. Kisspeptin-54 stimulates the hypothalamic-pituitary-gonadal axis in human males. JCEM (2005). — pubmed.ncbi.nlm.nih.gov/16131578
- George JT et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. JCEM (2011). — pubmed.ncbi.nlm.nih.gov/21752890
- Jayasena CN et al. Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers. JCEM (2013). — pubmed.ncbi.nlm.nih.gov/24081742
- Skorupskaite K et al. The kisspeptin-GnRH pathway in human reproductive health and disease. Human Reproduction Update (2014). — pubmed.ncbi.nlm.nih.gov/24615662
Considering Kisspeptin-10?
A Kindr Health physician reviews every longevity intake — peptides are prescribed only when medically indicated based on your history and labs. There is no charge for the initial review.
Related peptides
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
Last reviewed July 3, 2026. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products. Prescriptions require a clinical evaluation; a Kindr Health physician determines eligibility. Not for use in pregnancy. This page provides educational information and is not medical advice.